The Forced Evolutionary Virus (FEV), repurposed from the Pan-Immunity Virion Project, was formally developed in 2075. West Tek shifted its focus from immunization to forced genetic evolution following military interest. Originally intended as a cure for the New Plague and to combat biochemical warfare, FEV became instrumental in creating super-soldiers with heightened physical and cognitive traits. This report examines FEV’s applications from 2075 onwards, including its transfer to military facilities such as the Mariposa Base, marking a critical moment in pre-war U.S. military bioweapon development.
After its inception, FEV’s testing focused on generating controlled mutations. Test subjects were exposed to high doses of the virus in controlled labs. These tests monitored for changes in physical strength, cognitive ability, and resilience to radiation. Key testing phases occurred at the Mariposa Military Base from 2076 onwards, involving more complex subjects. Human trials confirmed FEV’s ability to rapidly evolve biological traits, though many subjects experienced extreme deformities or psychological decline. Data from flatworm, primate, and human subjects were compiled into military reports.
| Test Subject | Strength Increase | Cognitive Improvement | Radiation Resistance |
|---|---|---|---|
| Chimpanzee | 35% | 10% | 80% |
| Human Test #1 | 40% | 15% | 85% |
| Human Test #2 | 50% | 18% | 90% |
FEV demonstrated the ability to enhance physical attributes and mental acuity, though it often resulted in severe genetic deformities. The military's interest grew as successful trials on primates and humans confirmed increased strength and resistance to radiation, critical for the post-nuclear battlefield. By 2077, FEV became a cornerstone in U.S. biological warfare, despite ethical concerns. FEV strains were deployed to military installations such as Mariposa and later distributed to various Vaults, solidifying West Tek’s role in shaping pre-war bioengineering advancements.